Clinical Trial Update: Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of combining camizestrant with ribociclib in hormone receptor-positive breast cancer; currently not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• Camizestrant
• Ribociclib (ribociclib)

Snippet

Sponsor: MedSIR | Conditions: Hormon Receptor Positive Breast Cancer, Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING